It's an educated guess, but realistically, they have the data necessary to obtain a grant. it would be too easy.
They have shown, through ICS, that Cvac targets MUC-1 tumours.
They have shown, through Phase I and IIa clinical trials, that Cvac can achieve results in Ovarian Cancer
It was shown to be safe.
They will surely get a grant for phase I trial in another cancer. they are not looking to start up a Phase II/III trial. My only concern is, that while cash won't be put towards other cancers, is that other resources will be. I would like to see them achieve some significant milestones first before they expand. Perhaps they are "sure" about the Phase IIb results, or they are happy with can-004 recruitment. But until we know about it, it leaves a certain amount of uncertainty in shareholders minds.
- Forums
- ASX - By Stock
- todays shareholder meeting in perth
It's an educated guess, but realistically, they have the data...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.5¢ |
Change
-0.005(1.67%) |
Mkt cap ! $428.5M |
Open | High | Low | Value | Volume |
30.5¢ | 31.3¢ | 29.3¢ | $1.323M | 4.421M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 111754 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 61590 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 111754 | 0.295 |
24 | 520747 | 0.290 |
19 | 190996 | 0.285 |
28 | 1302132 | 0.280 |
5 | 181301 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 61590 | 3 |
0.305 | 86660 | 3 |
0.310 | 524960 | 8 |
0.315 | 35744 | 2 |
0.320 | 37936 | 2 |
Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |